rs201836020

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_024164.6(TPSB2):​c.68G>T​(p.Gly23Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 9/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G23A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.33 ( 57 hom., cov: 25)
Exomes 𝑓: 0.22 ( 609 hom. )
Failed GnomAD Quality Control

Consequence

TPSB2
NM_024164.6 missense

Scores

2
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0650

Publications

14 publications found
Variant links:
Genes affected
TPSB2 (HGNC:14120): (tryptase beta 2) Tryptases comprise a family of trypsin-like serine proteases, the peptidase family S1. Tryptases are enzymatically active only as heparin-stabilized tetramers, and they are resistant to all known endogenous proteinase inhibitors. Several tryptase genes are clustered on chromosome 16p13.3. These genes are characterized by several distinct features. They have a highly conserved 3' UTR and contain tandem repeat sequences at the 5' flank and 3' UTR which are thought to play a role in regulation of the mRNA stability. These genes have an intron immediately upstream of the initiator Met codon, which separates the site of transcription initiation from protein coding sequence. This feature is characteristic of tryptases but is unusual in other genes. The alleles of this gene exhibit an unusual amount of sequence variation, such that the alleles were once thought to represent two separate genes, beta II and beta III. Beta tryptases appear to be the main isoenzymes expressed in mast cells, whereas in basophils, alpha-tryptases predominate. Tryptases have been implicated as mediators in the pathogenesis of asthma and other allergic and inflammatory disorders. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002231419).
BP6
Variant 16-1229731-C-A is Benign according to our data. Variant chr16-1229731-C-A is described in ClinVar as Benign. ClinVar VariationId is 403562.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024164.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TPSB2
NM_024164.6
MANE Select
c.68G>Tp.Gly23Val
missense
Exon 3 of 6NP_077078.5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TPSB2
ENST00000606293.5
TSL:1 MANE Select
c.68G>Tp.Gly23Val
missense
Exon 3 of 6ENSP00000482743.1P20231
TPSB2
ENST00000612142.2
TSL:1
c.89G>Tp.Gly30Val
missense
Exon 2 of 5ENSP00000478695.1A0A087WUI4
TPSB2
ENST00000611196.4
TSL:1
n.68G>T
non_coding_transcript_exon
Exon 3 of 8ENSP00000484461.1A0A087X1U0

Frequencies

GnomAD3 genomes
AF:
0.328
AC:
42146
AN:
128340
Hom.:
57
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.277
Gnomad AMI
AF:
0.332
Gnomad AMR
AF:
0.307
Gnomad ASJ
AF:
0.320
Gnomad EAS
AF:
0.440
Gnomad SAS
AF:
0.325
Gnomad FIN
AF:
0.421
Gnomad MID
AF:
0.286
Gnomad NFE
AF:
0.341
Gnomad OTH
AF:
0.326
GnomAD2 exomes
AF:
0.241
AC:
37070
AN:
153848
AF XY:
0.240
show subpopulations
Gnomad AFR exome
AF:
0.166
Gnomad AMR exome
AF:
0.190
Gnomad ASJ exome
AF:
0.251
Gnomad EAS exome
AF:
0.361
Gnomad FIN exome
AF:
0.346
Gnomad NFE exome
AF:
0.233
Gnomad OTH exome
AF:
0.240
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR;InbreedingCoeff
AF:
0.225
AC:
234565
AN:
1043948
Hom.:
609
Cov.:
71
AF XY:
0.235
AC XY:
123824
AN XY:
527044
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.182
AC:
4511
AN:
24732
American (AMR)
AF:
0.282
AC:
10022
AN:
35504
Ashkenazi Jewish (ASJ)
AF:
0.296
AC:
6156
AN:
20806
East Asian (EAS)
AF:
0.436
AC:
15189
AN:
34852
South Asian (SAS)
AF:
0.296
AC:
20255
AN:
68476
European-Finnish (FIN)
AF:
0.413
AC:
18175
AN:
44034
Middle Eastern (MID)
AF:
0.239
AC:
833
AN:
3486
European-Non Finnish (NFE)
AF:
0.193
AC:
147993
AN:
767264
Other (OTH)
AF:
0.255
AC:
11431
AN:
44794
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.392
Heterozygous variant carriers
0
13842
27684
41527
55369
69211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2966
5932
8898
11864
14830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR;InbreedingCoeff
AF:
0.328
AC:
42166
AN:
128432
Hom.:
57
Cov.:
25
AF XY:
0.330
AC XY:
20686
AN XY:
62726
show subpopulations
African (AFR)
AF:
0.277
AC:
9347
AN:
33716
American (AMR)
AF:
0.307
AC:
4004
AN:
13026
Ashkenazi Jewish (ASJ)
AF:
0.320
AC:
985
AN:
3080
East Asian (EAS)
AF:
0.440
AC:
1849
AN:
4202
South Asian (SAS)
AF:
0.325
AC:
1243
AN:
3824
European-Finnish (FIN)
AF:
0.421
AC:
3801
AN:
9026
Middle Eastern (MID)
AF:
0.278
AC:
69
AN:
248
European-Non Finnish (NFE)
AF:
0.341
AC:
20018
AN:
58702
Other (OTH)
AF:
0.323
AC:
581
AN:
1798
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.432
Heterozygous variant carriers
0
1455
2910
4365
5820
7275
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
522
1044
1566
2088
2610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.228
Hom.:
40
ExAC
AF:
0.243
AC:
29238

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Uncertain
0.065
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
11
DANN
Benign
0.96
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.66
FATHMM_MKL
Benign
0.047
N
LIST_S2
Benign
0.74
T
MetaRNN
Benign
0.0022
T
MetaSVM
Benign
-0.50
T
PhyloP100
0.065
PrimateAI
Uncertain
0.64
T
Sift4G
Benign
0.33
T
Vest4
0.10
ClinPred
0.019
T
GERP RS
0.77
PromoterAI
-0.042
Neutral
gMVP
0.60
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201836020; hg19: chr16-1279732; COSMIC: COSV52352433; COSMIC: COSV52352433; API